Stephen Willard
Chief Executive Officer at NRX PHARMACEUTICALS, INC.
Net worth: 329 700 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jonathan Javitt | M | 67 | 7 years | |
| Kevin Walsh | M | - |
Global Life Technologies Corp.
 Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
| John Willimann | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
| Rick Panicucci | M | 63 | - | |
| Richard Narido | M | 46 | 1 years | |
| Patrick J. Flynn | M | 75 | 3 years | |
| Philippe Touret | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
| Ari Helenius | M | - |
Yale University
| 41 years |
| Chaim Hurvitz | M | 63 | 3 years | |
| Dennis K. McBride | M | - | 9 years | |
| Dario Gil | M | - |
The National Science Board
| - |
| Suresh Garimella | M | 60 |
The National Science Board
| - |
| Ellen Ochoa | M | 65 |
The National Science Board
| - |
| Eric Lauzat | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
| Heather A. Wilson | M | 63 |
The National Science Board
| - |
| Alan Leshner | M | - |
The National Science Board
| - |
| Janet Rehnquist | F | - | 1 years | |
| France Córdova | M | 84 |
The National Science Board
| - |
| Carrie M. Carretta | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gérard Soula | M | 78 |
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | 15 years |
| Robert Lilien | M | 62 | 9 years | |
| Karl Roessner | M | 56 | 10 years | |
| Arlen W. Gelbard | M | 66 |
E*TRADE Bank
 E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 8 years |
| Peter R. Knitzer | M | 65 |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 1 years |
| Robert V. Burton | M | - |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 4 years |
| Frank J. Petrilli | M | 73 | 1 years | |
| Greg Framke | M | 64 | 13 years | |
| Michael E. Foley | M | 71 | 4 years | |
| Bryon McGregor | M | 60 | 6 years | |
| Joseph Velli | M | 66 |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 4 years |
| Steven Freiberg | M | 67 | 2 years | |
| Matt Greenfield | M | - |
Yale University
| 16 years |
| Rodger Lawson | M | 77 | 8 years | |
| Rebecca Saeger | F | 69 |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 8 years |
| Robert Druskin | M | 76 | 3 years | |
| Russell Elmer | M | 59 | 9 years | |
| Christian Kalita | M | - |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Alessandra Daigneault | F | 61 | 1 years | |
| Craig R. Stapleton | M | 79 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Jeffrey S. Haber | M | - |
Yale University
| 7 years |
| Catherine Bréchignac | M | 77 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Miguel A. Rodriguez | M | 71 |
Yale University
| 4 years |
| Bart H. Williams | M | - |
Yale University
| 3 years |
| Mark Nydam | M | - |
Yale University
| 5 years |
| Robert D. Wilder | M | - |
Yale University
| 4 years |
| Frederick Wilkinson Kanner | M | 81 | 10 years | |
| Aaron Kaslow | M | 59 |
Yale University
| 7 years |
| Alexander F. Cohen | M | - |
Yale University
| 4 years |
| Alan Rudolph | M | - |
Cellphire, Inc.
 Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | 3 years |
| Dan Troy | M | 64 | 1 years | |
| James Lam | M | 63 | 8 years | |
| V. C. O. B. J. Navarre | M | 65 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Guillaume Cerutti | M | 58 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Phillandas T. Thompson | M | 50 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Maria Zuber | M | 66 |
The National Science Board
| 8 years |
| Todd Mackay | M | 50 | 11 years | |
| Herbert McMaster | M | 61 | 1 years | |
| Robert Besthof | M | 59 | 2 years | |
| Ryan Sheffield | M | - | 2 years | |
| David S. Blatt | M | - |
Yale University
| 7 years |
| Paul Idzik | M | 62 | 3 years | |
| Robert Glaser | M | 62 |
Yale University
| 4 years |
| Donald Layton | M | 73 | 2 years | |
| Ronald Fisher | M | 76 | 13 years | |
| Mitchell Caplan | M | 66 | 4 years | |
| C. Cathleen Raffaeli | F | 68 | 8 years | |
| Robert Simmons | M | 61 | 7 years | |
| Richard J. Carbone | M | 76 | 7 years | |
| Joseph L. Sclafani | M | 75 | - | |
| Seth van Voorhees | M | 63 | 1 years | |
| Benoit C. van Assche | M | 78 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Michael Shannon Anderson | M | 75 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Jon Kayyem | M | 60 |
Yale University
| 5 years |
| Christopher M. Flink | M | 52 | 2 years | |
| David I. Bokman | M | - |
Yale University
| 8 years |
| Lodewijk J. R. de Vink | M | 78 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Molly Cogan | F | - | - | |
| Lewis E. Randall | M | 82 | 30 years | |
| Cheryl Irene Smith | M | - |
Yale University
| 7 years |
| John W. Campbell | M | - |
Yale University
| 3 years |
| Patrick Ennis | M | 61 |
Yale University
| 6 years |
| David Ezra Gerstenhaber | M | 63 |
Yale University
| 3 years |
| Ken Griffin | M | - | 4 years | |
| John Ludwig Vogelstein | M | 89 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Francis J. T. Fildes | M | 79 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
| Barry David Kupferberg | M | - |
Yale University
| 4 years |
| Arie Soelendro | M | 77 |
Yale University
| - |
| Joe Dannenmaier | M | - |
Yale University
| 4 years |
| Henry E. Hooper | M | - |
Yale University
| 2 years |
| Gretchen L. Temeles | M | - |
Yale University
| 3 years |
| Elise Lufkin | F | - |
Yale University
| 4 years |
| Paul Carey Konigsberg | M | - |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 3 years |
| Kevin Francis Granger | M | 59 |
Yale University
| 4 years |
| Herbert Allen | M | - |
Yale University
| 4 years |
| Anne-Marie Fink | F | - |
Yale University
| 4 years |
| James Shifren | M | - |
Yale University
| 4 years |
| Jim Ayer | M | - |
Yale University
| 4 years |
| Frank Douthit Bracken | M | 60 |
Yale University
| 4 years |
| Manuel G.R. Rivera | M | - |
Yale University
| 4 years |
| Dean J. Takahashi | M | - |
Yale University
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 88 | 88.00% |
| France | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Willard
- Personal Network